These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 932193

  • 1. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
    Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW.
    Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
    [Abstract] [Full Text] [Related]

  • 4. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A.
    Minerva Med; 1979 Dec 01; 70(54):3705-7. PubMed ID: 523001
    [Abstract] [Full Text] [Related]

  • 5. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S, Christiansen C, Christensen MS, Naestoft J.
    Clin Nephrol; 1981 Jan 01; 15(1):23-7. PubMed ID: 7214749
    [Abstract] [Full Text] [Related]

  • 6. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 7. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man.
    Muirhead N, Catto GR, Gvozdanovic S, Gvozdanovic D, Edward N.
    Clin Sci (Lond); 1981 Dec 01; 61(6):723-7. PubMed ID: 6975197
    [Abstract] [Full Text] [Related]

  • 8. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
    Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL.
    J Clin Invest; 1977 Jul 01; 60(1):253-9. PubMed ID: 874087
    [Abstract] [Full Text] [Related]

  • 9. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS, Sevastikoglou JA, Lindgren U.
    Clin Orthop Relat Res; 1978 Sep 01; (135):226-31. PubMed ID: 709935
    [Abstract] [Full Text] [Related]

  • 10. Intestinal phosphate absorption in normal and uremic man: effects of 1,25(OH)2-vitamin D3 and 1alpha(OH)-vitamin D3.
    Coburn JW, Brickman AS, Hartenbower DL, Norman AW.
    Adv Exp Med Biol; 1977 Sep 01; 81():549-57. PubMed ID: 899939
    [No Abstract] [Full Text] [Related]

  • 11. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR, Baylink DJ, Jones PG, Haussler MR.
    J Clin Invest; 1976 Jul 01; 58(1):61-70. PubMed ID: 1084355
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985 Jul 01; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 13. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
    Gennari C, Agnusdei D, Nardi P, Civitelli R.
    J Clin Endocrinol Metab; 1990 Nov 01; 71(5):1288-93. PubMed ID: 2229286
    [Abstract] [Full Text] [Related]

  • 14. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ, Ritter CS, Weiskopf AS, Vouros P, Sasso GJ, Uskokovic MR, Wang G, Reddy GS.
    J Cell Biochem; 2005 Oct 15; 96(3):569-78. PubMed ID: 16088954
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA, Woodhead JS, Brown RC.
    Nephrol Dial Transplant; 1988 Oct 15; 3(1):70-6. PubMed ID: 3132643
    [Abstract] [Full Text] [Related]

  • 16. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R, Verstuyf A, Branisteanu D, Waer M, Mathieu C.
    Verh K Acad Geneeskd Belg; 1995 Oct 15; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [Abstract] [Full Text] [Related]

  • 17. Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity.
    Meyrier A, Valeyre D, Bouillon R, Paillard F, Battesti JP, Georges R.
    Q J Med; 1985 Mar 15; 54(215):269-81. PubMed ID: 3838815
    [Abstract] [Full Text] [Related]

  • 18. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
    Neer RM, Holick MF, DeLuca HF, Potts JT.
    Metabolism; 1975 Dec 15; 24(12):1403-13. PubMed ID: 1196134
    [Abstract] [Full Text] [Related]

  • 19. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
    Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF.
    J Clin Invest; 1979 Sep 15; 64(3):729-36. PubMed ID: 468987
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb 15; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.